Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Otezla
Pharma
Sotyktu has excelled in 2 psoriatic arthritis trials, BMS says
BMS has reported that two phase 3 trials of Sotyktu in psoriatic arthritis have achieved their primary endpoints.
Kevin Dunleavy
Dec 23, 2024 11:25am
Amgen tipped to keep Otezla market share in BMS' Sotyktu fight
Sep 5, 2023 7:25am
Arcutis launches branded Zoryve ad for a 'Cream That Can'
Aug 29, 2023 10:00am
Amgen runs lighthearted Otezla ad as psoriasis market heats up
Aug 15, 2023 7:55am
AbbVie's Skyrizi tops Amgen's Otezla in head-to-head study
Jul 26, 2023 10:45am
Amgen chalks up appeals win against Otezla generics
Apr 20, 2023 11:08am